Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04739670
Title Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer (BELLA)
Acronym BELLA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Royal North Shore RECRUITING St Leonards New South Wales 2065 Australia Details
Mater Health RECRUITING South Brisbane Queensland 4101 Australia Details
Monash Health RECRUITING Melbourne Victoria Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field